Variability of Heart Rate as a Marker of Complication of Colorectal Surgery
VFC COLORECTAL
1 other identifier
observational
117
1 country
1
Brief Summary
Heart rate variability reflects the autonomic nervous system on the intrinsic activity of sinus node cells. Sympathetic hyperactivity is an adaptation to stress, while parasympathetic hyperactivity is present at rest. Thus, any variability in the heart frequency rate reflects variations in sympathetic and parasympathetic components in the autonomic nervous system. Failure to return to normal or a reduction in the variability of the heart rate in the postoperative period is correlated with complications in colorectal surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 27, 2020
CompletedFirst Posted
Study publicly available on registry
April 29, 2020
CompletedStudy Start
First participant enrolled
June 17, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedMarch 21, 2022
August 1, 2021
4 years
April 27, 2020
March 18, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
Rate of variability of the heart rate between Day-1 to Day 7
Measured by power spectral density; ratio of the high to low frequencies
Day 7
Correlation between the rate of variability of the heart rate between Day-1 to Day 7and anastomotic fistula diagnosed according to Center for Diseases Control criteria after scheduled colorectal surgery
Abdominal-pelvic imagery
Hospital discharge (maximum Day 7)
Correlation between the rate of variability of the heart rate between Day-1 to Day 7 and peri-anastomotic fluid collections after scheduled colorectal surgery
Abdominal-pelvic imagery
Hospital discharge (maximum Day 7)
Secondary Outcomes (12)
Correlation between the rate of variability of the heart rate between Day-1 to Day 7 and presence of intra abdominal abscess
Hospital discharge (maximum Day 7)
Correlation between the rate of variability of the heart rate between Day-1 to Day 7 and presence of gut wall abscess
Hospital discharge (maximum Day 7)
Correlation between the rate of variability of the heart rate between Day-1 to Day 7 and presence of pneumonia
Hospital discharge (maximum Day 7)
Correlation between the rate of variability of the heart rate between Day-1 to Day 7 and presence of urinary tract infection
Hospital discharge (maximum Day 7)
Correlation between the rate of variability of the heart rate between Day-1 to Day 7 and presence of central venous catheter infection
Hospital discharge (maximum Day 7)
- +7 more secondary outcomes
Study Arms (1)
Patients undergoing colorectal surgery
Interventions
Heart rate and RR interval Post-anonymized analysis of heart rate variability using the KUBIOS software
Eligibility Criteria
All patients undergoing scheduled colorectal resection or operated on in the digestive surgery department of the CHU Nîmes
You may qualify if:
- Patients operated for a scheduled colorectal resection due to cancer, diverticulitis, or Chronic Inflammatory Bowel Disease,
- American Society of Anesthesiologists score 1-2
- The patient must have given their free and informed consent and signed the consent form
- The patient must be a member or beneficiary of a health insurance plan
You may not qualify if:
- Patient taking antidepressants, antipsychotics, antihypertensive beta blocker type, anti-arythmic or oral contraception
- Uncontrolled diabetes or associated with a neuropathy
- Arrhythmias and conduction disturbances, , coronaropathy and heart failure, kidney failure
- Neuropathies
- Pacemaker or defibrillator
- The subject refuses to sign the consent
- It is impossible to give the subject informed information
- The patient is under safeguard of justice or state guardianship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Nimes
Nîmes, France
Study Officials
- PRINCIPAL INVESTIGATOR
Martin Bertrand
CHU Nimes
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 27, 2020
First Posted
April 29, 2020
Study Start
June 17, 2020
Primary Completion
June 1, 2024
Study Completion
June 1, 2024
Last Updated
March 21, 2022
Record last verified: 2021-08